Resultados da pesquisa - (( drugs does devel ther ) OR ( drug ((doses devoid) OR (dermis depend)) ther ))*

A carregar...

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does...

Por Kim, Choon Ok, Oh, Eun Sil, Kim, Hohyun, Park, Min Soo
Publicado no Drug Des Devel Ther (2017)

“..., this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Cardioprotection with halogenated gases: how does it occur?

Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)

“... is related to the dose-dependent signal, while the degree of protection is related to the concentration...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does...

Por Thakkar, Disha, Dash, Ranjeet Prasad
Publicado no Drug Des Devel Ther (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Low-dose metronomic oral dosing of a prodrug of Gemcitabine (LY2334737) causes anti-tumor effects in the absence of inhibition of systemic vasculogenesis

Por Francia, Giulio, Shaked, Yuval, Hashimoto, Kae, Sun, John, Yin, Melissa, Cesta, Carolyn, Xu, Ping, Man, Shan, Hackl, Christina, Stewart, Julie, Uhlik, Mark, Dantzig, Anne H., Foster, Stuart, Kerbel, Robert S.
Publicado em 2011

“... drugs at relatively low minimally toxic doses with no prolonged break periods; it is now showing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Paliperidone extended-release: does it have a place in antipsychotic therapy?

Por Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Publicado em 2011

“... pharmacological profile, including single dosing, predominantly renal excretion, low drug–drug interaction risk...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?

Por Morris, Vikky, Wagg, Adrian
Publicado em 2014

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?

Por Erkılıç, E, Kesimci, E, Alaybeyoğlu, F, Kılınç, I, Tural, R, Yazgan, A, Gümüş, T, Sepici Dinçel, A, Dumlu, EG, Kanbak, O
Publicado no Drug Des Devel Ther (2017)

“... for remifentanil depending on our study results....”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Drug design with Cdc7 kinase: a potential novel cancer therapy target

Por Sawa, Masaaki, Masai, Hisao
Publicado em 2009

“... therapies. Kinases are one of the most common drug targets with a potential for cancer therapy. Cell cycle...”
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Acetazolamide serves as selective delivery vehicle for dipeptide-linked drugs to renal cell carcinoma

Por Cazzamalli, Samuele, Dal Corso, Alberto, Neri, Dario
Publicado no Mol Cancer Ther (2016)

“.... The percentage of injected dose per gram in the tumor was dose-dependent and revealed optimal tumor:organ ratios...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review

Por Yu, Qiaowen, Guo, Qisen, Chen, Liangan, Liu, Shuwei
Publicado no Drug Des Devel Ther (2015)

“... potential drug target in lung cancer. However, CDH1 methylation does not correlate with other factors...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action

Por Vonderlin, Nadine, Fischer, Fathima, Zitron, Edgar, Seyler, Claudia, Scherer, Daniel, Thomas, Dierk, Katus, Hugo A, Scholz, Eberhard P
Publicado no Drug Des Devel Ther (2015)

“... that midazolam inhibits hERG channels in a concentration-dependent manner, yielding an IC(50) of 170 μM...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma

Por Hu, Fei, Miao, Lin, Zhao, Yu, Xiao, Yuan-Yuan, Xu, Qing
Publicado no Drug Des Devel Ther (2015)

“...) The expression levels of CXCR4 does not increase during local progression, however, CXCR4 expression increases...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation

Por Wu, Jianhui, Zhao, Ming, Wang, Yuji, Wang, Yaonan, Zhu, Haimei, Zhao, Shurui, Gui, Lin, Zhang, Xiaoyi, Peng, Shiqi
Publicado no Drug Des Devel Ther (2017)

“... cells. In vivo HMCEF dose dependently (0.2, 2 and 200 nmol/kg per day) slows tumor growth in treated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Paeoniflorin Improves Cardiac Function and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Rat Model of Acute Myocardial Infarction [Corrigendum]

Por Chen H, Dong Y, He X, Li J, Wang J
Publicado em 2020-11-01

“...Drug Design, Development and Therapy...”
Obter o texto integral

Artigo

A carregar...

Current and developing therapeutic agents in the treatment of Chagas disease

Por Apt, Werner
Publicado em 2010

“... in chronic cases, where optical microscopy does not detect parasites. Nifurtimox (NF) and benznidazole (BNZ...”
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

The use of lorcaserin in the management of obesity: a critical appraisal

Por Bai, Bo, Wang, Yu
Publicado em 2010

“... recent clinical trials. The available evidence indicates that this drug does not show unwanted effects...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

New developments in the management of partial-onset epilepsy: role of brivaracetam

Por Coppola, Giangennaro, Iapadre, Giulia, Operto, Francesca Felicia, Verrotti, Alberto
Publicado no Drug Des Devel Ther (2017)

“...Currently, a number of novel anticonvulsant drugs, the so-called third generation, are in various...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Rituximab for the treatment of rheumatoid arthritis: an update

Por Mok, Chi Chiu
Publicado em 2013

“... for the treatment of rheumatoid arthritis (RA) that does not respond adequately to disease-modifying antirheumatic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Review of the pharmacology and clinical studies of micafungin

Por Bormann, Alison M, Morrison, Vicki A
Publicado em 2009

“... once daily infusion and does not require dose adjustments for renal or moderate hepatic dysfunction...”
Obter o texto integral
Obter o texto integral

Artigo

A carregar...

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers

Por Cossu, Maria Vittoria, Cattaneo, Dario, Fucile, Serena, Pellegrino, Paolo, Baldelli, Sara, Cozzi, Valeria, Capetti, Amedeo, Clementi, Emilio
Publicado em 2014

“... and to optimize the dosing of the combination of the drugs isosorbide dinitrate, a nitric oxide donor...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
Seguinte
[3]

Refinar a Pesquisa